Dual Positive PD-L1 and CD8+TIL Represents a Predominant Subtype in NSCLC and Correlates with Augmented ImmunogenicitySi-Yang Liu,Zhong-Yi Dong,Wen-Zhao Zhong,Si-Pei Wu,Zhi Xie,Hai-Yan Tu,Yi Long WuJOURNAL OF THORACIC ONCOLOGY（2017）引用 0|浏览6暂无评分关键词PD-L1,Immunotherapy,NSCLC,CD8+TILAI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
